ROBERTSON MICHELLE
SEC CIK 1755098 · EDGAR
BoughtSold
Most active insiders at VSTM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Paterson Dan | Pres, CEO, Dir | — | $502.1K |
| 2 | Bunn Paul A. | Dir | — | $138.0K |
| 3 | Kauffman Michael | Dir | — | $85.5K |
| 4 | Calkins Daniel | CFO | — | $54.2K |
| 5 | Stuglik Brian M | Dir | — | $5,411 |
| 6 | Gagnon Robert E. | Dir | — | $2,587 |
| 7 | Tollefson Karin Anna | Dir | — | — |
| 8 | ROBERTSON MICHELLE | Dir | — | — |
| 9 | Kapur Anil | Dir | — | — |
| 10 | JOHNSON JOHN | Dir | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-26 18:19 | 2026-05-21 | VSTM | Verastem, Inc. | ROBERTSON MICHELLE | Dir | A - Grant | $0.00 | +36.0K | 52.7K | +216% | $0 | |
| D | 2026-02-19 | 2026-02-18 | GERN | GERON CORP | ROBERTSON MICHELLE | EVP, CFO | S - Sale+OE | $1.94 | -9,855 | 17.6K | -36% | -$19.1K |
| D | 2026-02-19 | 2026-02-18 | GERN | GERON CORP | ROBERTSON MICHELLE | EVP, CFO | M - OptEx | $0.00 | +27.5K | 27.5K | New | $0 |
| D | 2025-05-27 | 2025-05-22 | VSTM | Verastem, Inc. | ROBERTSON MICHELLE | Dir | A - Grant | $0.00 | +8,333 | 16.7K | +100% | $0 |
| D | 2024-06-20 | 2024-06-18 | VSTM | Verastem, Inc. | ROBERTSON MICHELLE | Dir | A - Grant | $0.00 | +8,333 | 8,333 | New | $0 |
| 2023-05-15 | 2023-05-11 | EDIT | Editas Medicine, Inc. | ROBERTSON MICHELLE | EVP, CFO | S - Sale | $9.87 | -949 | 106.6K | -0.9% | -$9,367 | |
| D | 2023-03-06 | 2023-03-02 | EDIT | Editas Medicine, Inc. | ROBERTSON MICHELLE | EVP, CFO | A - Grant | $0.00 | +31.5K | 107.7K | +41% | $0 |
| D | 2023-03-06 | 2023-03-03 | EDIT | Editas Medicine, Inc. | ROBERTSON MICHELLE | EVP, CFO | S - Sale | $8.89 | -184 | 107.6K | -0.2% | -$1,636 |
| 2023-02-15 | 2023-02-13 | EDIT | Editas Medicine, Inc. | ROBERTSON MICHELLE | EVP, CFO | S - Sale | $9.67 | -4,287 | 76.2K | -5% | -$41.5K | |
| 2023-01-12 | 2023-01-10 | EDIT | Editas Medicine, Inc. | ROBERTSON MICHELLE | EVP, CFO | S - Sale | $8.16 | -1,752 | 80.5K | -2% | -$14.3K | |
| 2022-12-06 | 2022-12-05 | EDIT | Editas Medicine, Inc. | ROBERTSON MICHELLE | EVP, CFO | S - Sale | $10.23 | -193 | 82.3K | -0.2% | -$1,974 | |
| 2022-09-08 | 2022-09-06 | EDIT | Editas Medicine, Inc. | ROBERTSON MICHELLE | EVP, CFO | S - Sale | $15.01 | -192 | 82.5K | -0.2% | -$2,882 | |
| 2022-06-06 | 2022-06-03 | EDIT | Editas Medicine, Inc. | ROBERTSON MICHELLE | EVP, CFO | S - Sale | $11.54 | -1,527 | 82.7K | -2% | -$17.6K | |
| 2022-03-07 | 2022-03-03 | EDIT | Editas Medicine, Inc. | ROBERTSON MICHELLE | EVP, CFO | S - Sale | $17.33 | -767 | 84.2K | -0.9% | -$13.3K | |
| D | 2022-02-11 | 2022-02-10 | EDIT | Editas Medicine, Inc. | ROBERTSON MICHELLE | CFO | A - Grant | $0.00 | +53.5K | 85.0K | +170% | $0 |
| 2022-01-13 | 2022-01-11 | EDIT | Editas Medicine, Inc. | ROBERTSON MICHELLE | CFO | S - Sale | $25.70 | -1,744 | 31.5K | -5% | -$44.8K | |
| 2021-12-23 | 2021-12-22 | EDIT | Editas Medicine, Inc. | ROBERTSON MICHELLE | CFO | A - Grant | $0.00 | +4,471 | 33.2K | +16% | $0 | |
| D | 2021-08-10 | 2021-08-09 | EDIT | Editas Medicine, Inc. | ROBERTSON MICHELLE | CFO | M - OptEx | $30.65 | +2,500 | 31.2K | +9% | +$76.6K |
| D | 2021-08-10 | 2021-08-09 | EDIT | Editas Medicine, Inc. | ROBERTSON MICHELLE | CFO | S - Sale+OE | $60.00 | -2,500 | 28.7K | -8% | -$150.0K |
Purchase Sale Sale after option exercise All abbreviations